Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

FORM by GBY vs Found

Two GLP-1 desks, one scoreboard. We put FORM by GBY and Found head-to-head on the published Brief Score — the same six factors, scored the same way.

No. 196 · Grade C

FORM by GBY

Visit FORM by GBY Full brief →
vs
Higher Brief ScoreNo. 33 · Grade B−

Found

Visit Found Full brief →

The verdict

Found takes this head-to-head.

Found scores 81 to 67 on our six-factor Brief Score — The widest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.

That doesn't make FORM by GBY a bad call — it's best for readers who want the widest single-account menu and are willing to complete intake to learn what the branded and adjacent-care lines actually cost. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
55
84
Supply Reliability
78
88
Transparency
42
62
Access Breadth
82
92
Clinical Oversight
60
90
Track Record
68
86
FORM by GBYBrief Score 67 · 81Found

Price, coverage & the tracker

FORM by GBYFound
Brief Score67/100 (C)81/100 (B−)
Semaglutide$299/mo (compounded, no dose tiers published)$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still sits before a ~$30 per-visit copay
TirzepatideNot disclosed (Zepbound membership offered, drug cost not published)$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules
Coverage48 states + DC (excludes Alaska, Mississippi)All 50 states
Brand-name accessYesYes
Oral / sublingualYesYes
On the trackerNewnew to the tracker, no prior readingStableprice stable

FORM by GBY: First reading — one real price (compounded sema $299); everything else, including the advertised Wegovy "$95," is a membership fee or undisclosed.

Found: Headline unchanged, but our $129 line was wrong: the published floor is $99 and it requires a 3-, 6- or 12-month plan.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.